Transcatheter Closure of Atrial and Ventricular Septal Defects: JACC Focus Seminar
Mariel E Turner, Ismail Bouhout, Christopher J Petit, David Kalfa, Mariel E Turner, Ismail Bouhout, Christopher J Petit, David Kalfa
Abstract
The field of congenital interventional cardiology has experienced tremendous growth in recent years. Beginning with the development of early devices for transcatheter closure of septal defects in the 1970s and 1980s, such technologies have evolved to become a mainstay of treatment for many atrial septal defects (ASDs) and ventricular septal defects (VSDs). Percutaneous device closure is now the preferred approach for the majority of secundum ASDs. It is also a viable treatment option for selected VSDs, though limitations still exist. In this review, the authors describe the current state of transcatheter closure of ASDs and VSDs in children and adults, including patient selection, procedural approach, and outcomes. Potential areas for future evolution and innovation are also discussed.
Keywords: atrial septal defect; congenital heart disease; interventional cardiology; transcatheter device closure; ventricular septal defect.
Conflict of interest statement
Funding Support and Author Disclosures The authors have reported that they have no relationships relevant to the contents of this paper to disclose.
Copyright © 2022 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.
Source: PubMed